aluates Reports

$ 0.0

Automative

Global Women's Health Market Research Report 2026

Published Date: 2026-04-08

Report Code: QYRE-Auto-39D8997

Global Women s Health Market Insights and Forecast to 2028

BUY CHAPTERS

Global Women's Health Market Research Report 2026

Code: QYRE-Auto-39D8997

Report

2026-04-08

Pages:126

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck

Ferring

Eli Lilly

Pfizer Inc

AbbVie

Abbott

Theramex

Foundation Consumer Healthcare

Merck KGaA

Bayer

Amgen Inc

Livzon Pharmaceuticals

Xianjun Pharmaceuticals

Zizhu Pharmaceuticals

Qianjin Pharmaceuticals

Women's Health Market Size

The global Women's Health market was valued at US$ 36700 million in 2025 and is anticipated to reach US$ 47790 million by 2032, at a CAGR of 3.9% from 2026 to 2032.

Women's Health Market

Women's health refers to the branch of healthcare that focuses on the unique medical needs of women throughout different stages of life, from puberty to menopause and beyond. It includes a wide range of conditions and treatments related to reproductive health, hormonal imbalances, pregnancy, breast health, osteoporosis, and mental well-being. Women's health also covers issues like sexual health, contraception, fertility, and gynecological diseases such as endometriosis and polycystic ovary syndrome (PCOS). Recognizing that women experience health issues differently than men, this field emphasizes gender-specific research and treatments tailored to the physiological, psychological, and social needs of women.

Market Driver: The increasing focus on women’s health, driven by a combination of greater awareness, advocacy, and healthcare advancements, is a major driver of the women’s health market. As women continue to seek more personalized and comprehensive care, demand for treatments addressing conditions like reproductive health, menopause, osteoporosis, breast cancer, and mental health is on the rise. This is further supported by the growing recognition of the need for gender-specific healthcare solutions, including pharmaceuticals, diagnostics, and wellness products. Additionally, the rise in women’s life expectancy and the increasing number of women in the workforce who are able to access healthcare resources have also contributed to the growth of this market.

Market Challenge: Despite the growing demand for women’s health products and services, the market faces several challenges, including underrepresentation of women in clinical research and the lack of tailored treatments for gender-specific health issues. Many medical studies have historically been conducted with a male-dominated sample, which leads to insufficient data on how treatments affect women differently. Moreover, there are still significant social and cultural barriers in certain regions that prevent women from accessing adequate healthcare or seeking treatments for issues like reproductive health or menopause. These challenges can slow market growth, limit access, and hinder the development of more effective and personalized care for women.

The main companies of Global Women's Health include Amgen, Bayer, Merck KGaA, etc. These top three companies hold a market share about 20%. Europe and North America are the leading production regions in the world. The product is mainly used in contraceptive pills.

This report delivers a comprehensive overview of the global Women's Health market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Women's Health. The Women's Health market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Women's Health market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Women's Health manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Women's Health Market Report

Report Metric	Details
Report Name	Women's Health Market
Accounted market size in 2025	US$ 36700 in million
Forecasted market size in 2032	US$ 47790 million
CAGR	3.9%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Hormone Therapy Nonhormonal Therapy
Segment by Application	Climacteric Postmenopausal Osteoporosis Contraceptive Pill Infertility Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amgen, Bayer, Merck KGaA, Merck & Co, Ferring, Eli Lilly, Pfizer, AbbVie, Abbott, Theramex, Livzon Pharmaceuticals, Foundation Consumer Healthcare, Xianjun Pharmaceuticals, Zizhu Pharmaceuticals, Qianjin Pharmaceuticals, Organon Pharma, Insud Pharma, Viatris, Teva, Hisamitsu
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Women's Health companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Women's Health Market growing?

Ans: The Women's Health Market witnessing a CAGR of 3.9% during the forecast period 2026-2032.

What is the Women's Health Market size in 2032?

Ans: The Women's Health Market size in 2032 will be US$ 47790 million.

What is the market share of major companies in Women's Health Market?

Ans: These top three companies hold a market share about 20%.

Who are the main players in the Women's Health Market report?

Ans: The main players in the Women's Health Market are Amgen, Bayer, Merck KGaA, Merck & Co, Ferring, Eli Lilly, Pfizer, AbbVie, Abbott, Theramex, Livzon Pharmaceuticals, Foundation Consumer Healthcare, Xianjun Pharmaceuticals, Zizhu Pharmaceuticals, Qianjin Pharmaceuticals, Organon Pharma, Insud Pharma, Viatris, Teva, Hisamitsu

What are the Application segmentation covered in the Women's Health Market report?

Ans: The Applications covered in the Women's Health Market report are Climacteric, Postmenopausal Osteoporosis, Contraceptive Pill, Infertility, Others

What are the Type segmentation covered in the Women's Health Market report?

Ans: The Types covered in the Women's Health Market report are Hormone Therapy, Nonhormonal Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Women's Health Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Hormone Therapy

1.2.3 Nonhormonal Therapy

1.3 Market by Application

1.3.1 Global Women's Health Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Climacteric

1.3.3 Postmenopausal Osteoporosis

1.3.4 Contraceptive Pill

1.3.5 Infertility

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Women's Health Market Perspective (2021–2032)

2.2 Global Women's Health Growth Trends by Region

2.2.1 Global Women's Health Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Women's Health Historic Market Size by Region (2021–2026)

2.2.3 Women's Health Forecasted Market Size by Region (2027–2032)

2.3 Women's Health Market Dynamics

2.3.1 Women's Health Industry Trends

2.3.2 Women's Health Market Drivers

2.3.3 Women's Health Market Challenges

2.3.4 Women's Health Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Women's Health Players by Revenue

3.1.1 Global Top Women's Health Players by Revenue (2021–2026)

3.1.2 Global Women's Health Revenue Market Share by Players (2021–2026)

3.2 Global Top Women's Health Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Women's Health Revenue

3.4 Global Women's Health Market Concentration Ratio

3.4.1 Global Women's Health Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Women's Health Revenue in 2025

3.5 Global Key Players of Women's Health Head Offices and Areas Served

3.6 Global Key Players of Women's Health, Products and Applications

3.7 Global Key Players of Women's Health, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Women's Health Breakdown Data by Type

4.1 Global Women's Health Historic Market Size by Type (2021–2026)

4.2 Global Women's Health Forecasted Market Size by Type (2027–2032)

5 Women's Health Breakdown Data by Application

5.1 Global Women's Health Historic Market Size by Application (2021–2026)

5.2 Global Women's Health Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Women's Health Market Size (2021–2032)

6.2 North America Women's Health Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Women's Health Market Size by Country (2021–2026)

6.4 North America Women's Health Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Women's Health Market Size (2021–2032)

7.2 Europe Women's Health Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Women's Health Market Size by Country (2021–2026)

7.4 Europe Women's Health Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Women's Health Market Size (2021–2032)

8.2 Asia-Pacific Women's Health Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Women's Health Market Size by Region (2021–2026)

8.4 Asia-Pacific Women's Health Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Women's Health Market Size (2021–2032)

9.2 Latin America Women's Health Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Women's Health Market Size by Country (2021–2026)

9.4 Latin America Women's Health Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Women's Health Market Size (2021–2032)

10.2 Middle East & Africa Women's Health Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Women's Health Market Size by Country (2021–2026)

10.4 Middle East & Africa Women's Health Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Amgen

11.1.1 Amgen Company Details

11.1.2 Amgen Business Overview

11.1.3 Amgen Women's Health Introduction

11.1.4 Amgen Revenue in Women's Health Business (2021–2026)

11.1.5 Amgen Recent Development

11.2 Bayer

11.2.1 Bayer Company Details

11.2.2 Bayer Business Overview

11.2.3 Bayer Women's Health Introduction

11.2.4 Bayer Revenue in Women's Health Business (2021–2026)

11.2.5 Bayer Recent Development

11.3 Merck KGaA

11.3.1 Merck KGaA Company Details

11.3.2 Merck KGaA Business Overview

11.3.3 Merck KGaA Women's Health Introduction

11.3.4 Merck KGaA Revenue in Women's Health Business (2021–2026)

11.3.5 Merck KGaA Recent Development

11.4 Merck & Co

11.4.1 Merck & Co Company Details

11.4.2 Merck & Co Business Overview

11.4.3 Merck & Co Women's Health Introduction

11.4.4 Merck & Co Revenue in Women's Health Business (2021–2026)

11.4.5 Merck & Co Recent Development

11.5 Ferring

11.5.1 Ferring Company Details

11.5.2 Ferring Business Overview

11.5.3 Ferring Women's Health Introduction

11.5.4 Ferring Revenue in Women's Health Business (2021–2026)

11.5.5 Ferring Recent Development

11.6 Eli Lilly

11.6.1 Eli Lilly Company Details

11.6.2 Eli Lilly Business Overview

11.6.3 Eli Lilly Women's Health Introduction

11.6.4 Eli Lilly Revenue in Women's Health Business (2021–2026)

11.6.5 Eli Lilly Recent Development

11.7 Pfizer

11.7.1 Pfizer Company Details

11.7.2 Pfizer Business Overview

11.7.3 Pfizer Women's Health Introduction

11.7.4 Pfizer Revenue in Women's Health Business (2021–2026)

11.7.5 Pfizer Recent Development

11.8 AbbVie

11.8.1 AbbVie Company Details

11.8.2 AbbVie Business Overview

11.8.3 AbbVie Women's Health Introduction

11.8.4 AbbVie Revenue in Women's Health Business (2021–2026)

11.8.5 AbbVie Recent Development

11.9 Abbott

11.9.1 Abbott Company Details

11.9.2 Abbott Business Overview

11.9.3 Abbott Women's Health Introduction

11.9.4 Abbott Revenue in Women's Health Business (2021–2026)

11.9.5 Abbott Recent Development

11.10 Theramex

11.10.1 Theramex Company Details

11.10.2 Theramex Business Overview

11.10.3 Theramex Women's Health Introduction

11.10.4 Theramex Revenue in Women's Health Business (2021–2026)

11.10.5 Theramex Recent Development

11.11 Livzon Pharmaceuticals

11.11.1 Livzon Pharmaceuticals Company Details

11.11.2 Livzon Pharmaceuticals Business Overview

11.11.3 Livzon Pharmaceuticals Women's Health Introduction

11.11.4 Livzon Pharmaceuticals Revenue in Women's Health Business (2021–2026)

11.11.5 Livzon Pharmaceuticals Recent Development

11.12 Foundation Consumer Healthcare

11.12.1 Foundation Consumer Healthcare Company Details

11.12.2 Foundation Consumer Healthcare Business Overview

11.12.3 Foundation Consumer Healthcare Women's Health Introduction

11.12.4 Foundation Consumer Healthcare Revenue in Women's Health Business (2021–2026)

11.12.5 Foundation Consumer Healthcare Recent Development

11.13 Xianjun Pharmaceuticals

11.13.1 Xianjun Pharmaceuticals Company Details

11.13.2 Xianjun Pharmaceuticals Business Overview

11.13.3 Xianjun Pharmaceuticals Women's Health Introduction

11.13.4 Xianjun Pharmaceuticals Revenue in Women's Health Business (2021–2026)

11.13.5 Xianjun Pharmaceuticals Recent Development

11.14 Zizhu Pharmaceuticals

11.14.1 Zizhu Pharmaceuticals Company Details

11.14.2 Zizhu Pharmaceuticals Business Overview

11.14.3 Zizhu Pharmaceuticals Women's Health Introduction

11.14.4 Zizhu Pharmaceuticals Revenue in Women's Health Business (2021–2026)

11.14.5 Zizhu Pharmaceuticals Recent Development

11.15 Qianjin Pharmaceuticals

11.15.1 Qianjin Pharmaceuticals Company Details

11.15.2 Qianjin Pharmaceuticals Business Overview

11.15.3 Qianjin Pharmaceuticals Women's Health Introduction

11.15.4 Qianjin Pharmaceuticals Revenue in Women's Health Business (2021–2026)

11.15.5 Qianjin Pharmaceuticals Recent Development

11.16 Organon Pharma

11.16.1 Organon Pharma Company Details

11.16.2 Organon Pharma Business Overview

11.16.3 Organon Pharma Women's Health Introduction

11.16.4 Organon Pharma Revenue in Women's Health Business (2021–2026)

11.16.5 Organon Pharma Recent Development

11.17 Insud Pharma

11.17.1 Insud Pharma Company Details

11.17.2 Insud Pharma Business Overview

11.17.3 Insud Pharma Women's Health Introduction

11.17.4 Insud Pharma Revenue in Women's Health Business (2021–2026)

11.17.5 Insud Pharma Recent Development

11.18 Viatris

11.18.1 Viatris Company Details

11.18.2 Viatris Business Overview

11.18.3 Viatris Women's Health Introduction

11.18.4 Viatris Revenue in Women's Health Business (2021–2026)

11.18.5 Viatris Recent Development

11.19 Teva

11.19.1 Teva Company Details

11.19.2 Teva Business Overview

11.19.3 Teva Women's Health Introduction

11.19.4 Teva Revenue in Women's Health Business (2021–2026)

11.19.5 Teva Recent Development

11.20 Hisamitsu

11.20.1 Hisamitsu Company Details

11.20.2 Hisamitsu Business Overview

11.20.3 Hisamitsu Women's Health Introduction

11.20.4 Hisamitsu Revenue in Women's Health Business (2021–2026)

11.20.5 Hisamitsu Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Merck

Ferring

Eli Lilly

Pfizer Inc

AbbVie

Abbott

Theramex

Foundation Consumer Healthcare

Merck KGaA

Bayer

Amgen Inc

Livzon Pharmaceuticals

Xianjun Pharmaceuticals

Zizhu Pharmaceuticals

Qianjin Pharmaceuticals

List of Tables

Table 1. Global Women's Health Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Hormone Therapy

Table 3. Key Players of Nonhormonal Therapy

Table 4. Global Women's Health Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Women's Health Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Women's Health Market Size by Region (US$ Million), 2021–2026

Table 7. Global Women's Health Market Share by Region (2021–2026)

Table 8. Global Women's Health Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Women's Health Market Share by Region (2027–2032)

Table 10. Women's Health Market Trends

Table 11. Women's Health Market Drivers

Table 12. Women's Health Market Challenges

Table 13. Women's Health Market Restraints

Table 14. Global Women's Health Revenue by Players (US$ Million), 2021–2026

Table 15. Global Women's Health Market Share by Players (2021–2026)

Table 16. Global Top Women's Health Players by Tier (Tier 1, Tier 2, and Tier 3), based on Women's Health Revenue, 2025

Table 17. Ranking of Global Top Women's Health Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Women's Health Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Women's Health, Headquarters and Area Served

Table 20. Global Key Players of Women's Health, Products and Applications

Table 21. Global Key Players of Women's Health, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Women's Health Market Size by Type (US$ Million), 2021–2026

Table 24. Global Women's Health Revenue Market Share by Type (2021–2026)

Table 25. Global Women's Health Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Women's Health Revenue Market Share by Type (2027–2032)

Table 27. Global Women's Health Market Size by Application (US$ Million), 2021–2026

Table 28. Global Women's Health Revenue Market Share by Application (2021–2026)

Table 29. Global Women's Health Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Women's Health Revenue Market Share by Application (2027–2032)

Table 31. North America Women's Health Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Women's Health Market Size by Country (US$ Million), 2021–2026

Table 33. North America Women's Health Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Women's Health Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Women's Health Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Women's Health Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Women's Health Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Women's Health Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Women's Health Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Women's Health Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Women's Health Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Women's Health Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Women's Health Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Women's Health Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Women's Health Market Size by Country (US$ Million), 2027–2032

Table 46. Amgen Company Details

Table 47. Amgen Business Overview

Table 48. Amgen Women's Health Product

Table 49. Amgen Revenue in Women's Health Business (US$ Million), 2021–2026

Table 50. Amgen Recent Development

Table 51. Bayer Company Details

Table 52. Bayer Business Overview

Table 53. Bayer Women's Health Product

Table 54. Bayer Revenue in Women's Health Business (US$ Million), 2021–2026

Table 55. Bayer Recent Development

Table 56. Merck KGaA Company Details

Table 57. Merck KGaA Business Overview

Table 58. Merck KGaA Women's Health Product

Table 59. Merck KGaA Revenue in Women's Health Business (US$ Million), 2021–2026

Table 60. Merck KGaA Recent Development

Table 61. Merck & Co Company Details

Table 62. Merck & Co Business Overview

Table 63. Merck & Co Women's Health Product

Table 64. Merck & Co Revenue in Women's Health Business (US$ Million), 2021–2026

Table 65. Merck & Co Recent Development

Table 66. Ferring Company Details

Table 67. Ferring Business Overview

Table 68. Ferring Women's Health Product

Table 69. Ferring Revenue in Women's Health Business (US$ Million), 2021–2026

Table 70. Ferring Recent Development

Table 71. Eli Lilly Company Details

Table 72. Eli Lilly Business Overview

Table 73. Eli Lilly Women's Health Product

Table 74. Eli Lilly Revenue in Women's Health Business (US$ Million), 2021–2026

Table 75. Eli Lilly Recent Development

Table 76. Pfizer Company Details

Table 77. Pfizer Business Overview

Table 78. Pfizer Women's Health Product

Table 79. Pfizer Revenue in Women's Health Business (US$ Million), 2021–2026

Table 80. Pfizer Recent Development

Table 81. AbbVie Company Details

Table 82. AbbVie Business Overview

Table 83. AbbVie Women's Health Product

Table 84. AbbVie Revenue in Women's Health Business (US$ Million), 2021–2026

Table 85. AbbVie Recent Development

Table 86. Abbott Company Details

Table 87. Abbott Business Overview

Table 88. Abbott Women's Health Product

Table 89. Abbott Revenue in Women's Health Business (US$ Million), 2021–2026

Table 90. Abbott Recent Development

Table 91. Theramex Company Details

Table 92. Theramex Business Overview

Table 93. Theramex Women's Health Product

Table 94. Theramex Revenue in Women's Health Business (US$ Million), 2021–2026

Table 95. Theramex Recent Development

Table 96. Livzon Pharmaceuticals Company Details

Table 97. Livzon Pharmaceuticals Business Overview

Table 98. Livzon Pharmaceuticals Women's Health Product

Table 99. Livzon Pharmaceuticals Revenue in Women's Health Business (US$ Million), 2021–2026

Table 100. Livzon Pharmaceuticals Recent Development

Table 101. Foundation Consumer Healthcare Company Details

Table 102. Foundation Consumer Healthcare Business Overview

Table 103. Foundation Consumer Healthcare Women's Health Product

Table 104. Foundation Consumer Healthcare Revenue in Women's Health Business (US$ Million), 2021–2026

Table 105. Foundation Consumer Healthcare Recent Development

Table 106. Xianjun Pharmaceuticals Company Details

Table 107. Xianjun Pharmaceuticals Business Overview

Table 108. Xianjun Pharmaceuticals Women's Health Product

Table 109. Xianjun Pharmaceuticals Revenue in Women's Health Business (US$ Million), 2021–2026

Table 110. Xianjun Pharmaceuticals Recent Development

Table 111. Zizhu Pharmaceuticals Company Details

Table 112. Zizhu Pharmaceuticals Business Overview

Table 113. Zizhu Pharmaceuticals Women's Health Product

Table 114. Zizhu Pharmaceuticals Revenue in Women's Health Business (US$ Million), 2021–2026

Table 115. Zizhu Pharmaceuticals Recent Development

Table 116. Qianjin Pharmaceuticals Company Details

Table 117. Qianjin Pharmaceuticals Business Overview

Table 118. Qianjin Pharmaceuticals Women's Health Product

Table 119. Qianjin Pharmaceuticals Revenue in Women's Health Business (US$ Million), 2021–2026

Table 120. Qianjin Pharmaceuticals Recent Development

Table 121. Organon Pharma Company Details

Table 122. Organon Pharma Business Overview

Table 123. Organon Pharma Women's Health Product

Table 124. Organon Pharma Revenue in Women's Health Business (US$ Million), 2021–2026

Table 125. Organon Pharma Recent Development

Table 126. Insud Pharma Company Details

Table 127. Insud Pharma Business Overview

Table 128. Insud Pharma Women's Health Product

Table 129. Insud Pharma Revenue in Women's Health Business (US$ Million), 2021–2026

Table 130. Insud Pharma Recent Development

Table 131. Viatris Company Details

Table 132. Viatris Business Overview

Table 133. Viatris Women's Health Product

Table 134. Viatris Revenue in Women's Health Business (US$ Million), 2021–2026

Table 135. Viatris Recent Development

Table 136. Teva Company Details

Table 137. Teva Business Overview

Table 138. Teva Women's Health Product

Table 139. Teva Revenue in Women's Health Business (US$ Million), 2021–2026

Table 140. Teva Recent Development

Table 141. Hisamitsu Company Details

Table 142. Hisamitsu Business Overview

Table 143. Hisamitsu Women's Health Product

Table 144. Hisamitsu Revenue in Women's Health Business (US$ Million), 2021–2026

Table 145. Hisamitsu Recent Development

Table 146. Research Programs/Design for This Report

Table 147. Key Data Information from Secondary Sources

Table 148. Key Data Information from Primary Sources

Table 149. Authors List of This Report

List of Figures

Figure 1. Women's Health Picture

Figure 2. Global Women's Health Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Women's Health Market Share by Type: 2025 vs 2032

Figure 4. Hormone Therapy Features

Figure 5. Nonhormonal Therapy Features

Figure 6. Global Women's Health Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Women's Health Market Share by Application: 2025 vs 2032

Figure 8. Climacteric Case Studies

Figure 9. Postmenopausal Osteoporosis Case Studies

Figure 10. Contraceptive Pill Case Studies

Figure 11. Infertility Case Studies

Figure 12. Others Case Studies

Figure 13. Women's Health Report Years Considered

Figure 14. Global Women's Health Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 15. Global Women's Health Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Women's Health Market Share by Region: 2025 vs 2032

Figure 17. Global Women's Health Market Share by Players in 2025

Figure 18. Global Women's Health Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Women's Health Revenue in 2025

Figure 20. North America Women's Health Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. North America Women's Health Market Share by Country (2021–2032)

Figure 22. United States Women's Health Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Canada Women's Health Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Women's Health Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Women's Health Market Share by Country (2021–2032)

Figure 26. Germany Women's Health Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. France Women's Health Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. U.K. Women's Health Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Italy Women's Health Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Russia Women's Health Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Ireland Women's Health Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Women's Health Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Women's Health Market Share by Region (2021–2032)

Figure 34. China Women's Health Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Japan Women's Health Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. South Korea Women's Health Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Southeast Asia Women's Health Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. India Women's Health Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Australia & New Zealand Women's Health Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Women's Health Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Women's Health Market Share by Country (2021–2032)

Figure 42. Mexico Women's Health Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Brazil Women's Health Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Women's Health Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Women's Health Market Share by Country (2021–2032)

Figure 46. Israel Women's Health Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Saudi Arabia Women's Health Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. UAE Women's Health Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Amgen Revenue Growth Rate in Women's Health Business (2021–2026)

Figure 50. Bayer Revenue Growth Rate in Women's Health Business (2021–2026)

Figure 51. Merck KGaA Revenue Growth Rate in Women's Health Business (2021–2026)

Figure 52. Merck & Co Revenue Growth Rate in Women's Health Business (2021–2026)

Figure 53. Ferring Revenue Growth Rate in Women's Health Business (2021–2026)

Figure 54. Eli Lilly Revenue Growth Rate in Women's Health Business (2021–2026)

Figure 55. Pfizer Revenue Growth Rate in Women's Health Business (2021–2026)

Figure 56. AbbVie Revenue Growth Rate in Women's Health Business (2021–2026)

Figure 57. Abbott Revenue Growth Rate in Women's Health Business (2021–2026)

Figure 58. Theramex Revenue Growth Rate in Women's Health Business (2021–2026)

Figure 59. Livzon Pharmaceuticals Revenue Growth Rate in Women's Health Business (2021–2026)

Figure 60. Foundation Consumer Healthcare Revenue Growth Rate in Women's Health Business (2021–2026)

Figure 61. Xianjun Pharmaceuticals Revenue Growth Rate in Women's Health Business (2021–2026)

Figure 62. Zizhu Pharmaceuticals Revenue Growth Rate in Women's Health Business (2021–2026)

Figure 63. Qianjin Pharmaceuticals Revenue Growth Rate in Women's Health Business (2021–2026)

Figure 64. Organon Pharma Revenue Growth Rate in Women's Health Business (2021–2026)

Figure 65. Insud Pharma Revenue Growth Rate in Women's Health Business (2021–2026)

Figure 66. Viatris Revenue Growth Rate in Women's Health Business (2021–2026)

Figure 67. Teva Revenue Growth Rate in Women's Health Business (2021–2026)

Figure 68. Hisamitsu Revenue Growth Rate in Women's Health Business (2021–2026)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Pharmaceuticals for Women s Health Market Research Report 2025

Global Women s Health Applications Market Research Report 2024

Global Female Health App Market Research Report 2025

Global Gynecology Drugs Market Research Report 2024

Global Women Health App Market Research Report 2025

Global Women Digital Health Solution Market Research Report 2024

Global Female Digital Health Platform Market Research Report 2024

Global Women Health Diagnostics Market Insights Forecast to 2030

Global Women Health Devices Market Insights Forecast to 2030

Global Women s Health Care Drugs Market Research Report 2024

Women s Health Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Women s Home based Health Testing Services Market Research Report 2025

Global Gynecological Medical Devices Market Research Report 2025

Global Reproductive Health Testing Market Research Report 2024

Global Reproductive Health Market Research Report 2024

Global Women Health Supplement Market Research Report 2024

Global Polycystic Ovary Syndrome PCOS Treatment Market Research Report 2024

Global Women s Health Ultrasound System Market Research Report 2024

Global Women Nutrition Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions